Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
Research and development tax reliefs are available for businesses in many countries, but some companies are not taking advantage.
A recently published report shows how the European Commission has protected patients against anticompetitive practices over the last decade.
EU will allow companies to carry out QC testing in the UK after a "no deal" Brexit, at least under certain conditions and for a limited time.
The potential market for complex generics is substantial, but navigating the FDA’s guidance for proving “sameness” is a real minefield...
What did the partial government shutdown mean for the US pharma industry?
Sitting Down With… Sir Alasdair Breckenridge; Chairman of the Advisory Board, the Centre of Regulatory Excellence of the Government of Singapore...
Gearing up for 2019, the EMA shares revised guidelines to better protect the environment.
Oscars of science, drug shortage reporting requirements, and a new gene therapy... What’s new for pharma in business?
The FDA’s Janet Woodcock explains how manufacturing will change in the coming years.
Mike Merges and Mike Sadick
Analytical bioassay cell banks certainly have benefits. But it can be difficult to know what best practices to follow.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.